Connection
Margaret Macy to National Cancer Institute (U.S.)
This is a "connection" page, showing publications Margaret Macy has written about National Cancer Institute (U.S.).
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.052 |
|
|
|
-
Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, Ladenstein RL, Baruchel S, Macy ME, Moreno L, Seibel NL, Pearson AD, Matthay KK, Valteau-Couanet D. Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer. 2022 11 01; 128(21):3775-3783.
Score: 0.052